O-1602, an Agonist of Atypical Cannabinoid Receptors GPR55, Reverses the Symptoms of Depression and Detrusor Overactivity in Rats Subjected to Corticosterone Treatment

Uroprotective effect of ambroxol in cyclophosphamide-induced cystitis in mice

(2019) Elif Nur Barut et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Influence of the CB1 cannabinoid receptors on the activity of the monoaminergic system in the behavioural tests in mice

(2019) Ewa Poleszak et al.   BRAIN RESEARCH BULLETIN

Molecular and functional interaction between GPR18 and cannabinoid CB 2 G-protein-coupled receptors. Relevance in neurodegenerative diseases

(2018) Irene Reyes-Resina et al.   BIOCHEMICAL PHARMACOLOGY

Orphan G protein-coupled receptors: The role in CNS disorders

(2018) Mohaddeseh Sadat Alavi et al.   BIOMEDICINE & PHARMACOTHERAPY

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

(2018) Andrea Cipriani et al.   LANCET

Alterations in Gene and Protein Expression of Cannabinoid CB2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims

(2018) María S. García-Gutiérrez et al.   Neurotherapeutics

Inhibition of Rho kinase by GSK 269962 reverses both corticosterone-induced detrusor overactivity and depression-like behaviour in rats

(2018) Andrzej Wróbel et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Activation of GPR55 induces neuroprotection of hippocampal neurogenesis and immune responses of neural stem cells following chronic, systemic inflammation

(2018) Jeremy D. Hill et al.   BRAIN BEHAVIOR AND IMMUNITY

Analysis of key genes and micro-RNA-mRNA regulatory networks in women with ulcerative interstitial cystitis/pain bladder syndrome

(2018) Shengzhuo Liu et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Cannabinoids in depressive disorders

(2018) Ewa Poleszak et al.   LIFE SCIENCES

A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity

(2017) Katrina Hurst et al.   HIPPOCAMPUS

Severe depression and anxiety in women with overactive bladder

(2017) Iane Glauce Ribeiro Melotti et al.   NEUROUROLOGY AND URODYNAMICS

The novel cannabinoid receptor GPR55 mediates anxiolytic-like effects in the medial orbital cortex of mice with acute stress

(2017) Qi-xin Shi et al.   Molecular Brain

GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans

(2016) Bo Liu et al.   DIABETES OBESITY & METABOLISM

Fourteen-day administration of corticosterone may induce detrusor overactivity symptoms

(2016) Andrzej Wróbel et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

The effect of combined treatment with a β3 AR agonist and a ROCK inhibitor on detrusor overactivity

(2016) Andrzej Wróbel et al.   NEUROUROLOGY AND URODYNAMICS

The effect of O-1602, an atypical cannabinoid, on morphine-induced conditioned place preference and physical dependence

(2016) Mohaddeseh Sadat Alavi et al.   Pharmacological Reports

Central administration of GPR55 receptor agonist and antagonist modulates anxiety-related behaviors in rats

(2015) Abbasali Rahimi et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Cannabinoid receptor expression in the bladder is altered in detrusor overactivity

(2015) Evangelia Bakali et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

The Effects of Tempol on Cyclophosphamide-Induced Oxidative Stress in Rat Micturition Reflexes

(2015) Eric J. Gonzalez et al.   TheScientificWorldJOURNAL

A new model of detrusor overactivity in conscious rats induced by retinyl acetate instillation

(2015) Andrzej Wróbel et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

The Effects of Tempol on Cyclophosphamide-Induced Oxidative Stress in Rat Micturition Reflexes

(2015) Eric J. Gonzalez et al.   Scientific World Journal

Activation of GPR18 by cannabinoid compounds: a tale of biased agonism

(2014) Linda Console-Bram et al.   BRITISH JOURNAL OF PHARMACOLOGY

The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells

(2014) Valerio Chiurchiù et al.   INTERNATIONAL IMMUNOLOGY

Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications

(2013) J.C. Felger et al.   NEUROSCIENCE

GPR55, a G-Protein Coupled Receptor for Lysophosphatidylinositol, Plays a Role in Motor Coordination

(2013) Chia-Shan Wu et al.   PLoS One

O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms

(2012) Julia Kargl et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

The atypical cannabinoid O-1602 increases hind paw sensitisation in the chronic constriction injury model of neuropathic pain

(2012) Courtney Breen et al.   NEUROSCIENCE LETTERS

Anti-Inflammatory Role of Cannabidiol and O-1602 in Cerulein-Induced Acute Pancreatitis in Mice

(2012) Kun Li et al.   PANCREAS

Risk Factors for New-onset Overactive Bladder in Older Subjects: Results of the Fujiwara-Kyo Study

(2012) Akihide Hirayama et al.   UROLOGY

Neurotrophins in the Lower Urinary Tract: Becoming of Age

(2011) Barbara Frias et al.   Current Neuropharmacology

The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats

(2011) A. Díaz-Arteaga et al.   DIABETES OBESITY & METABOLISM

A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents

(2011) X.-H. Lin et al.   NEUROGASTROENTEROLOGY AND MOTILITY

The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55

(2011) Niklas Schuelert et al.   NEUROSCIENCE LETTERS

N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor

(2010) Douglas McHugh et al.   BMC NEUROSCIENCE

Pharmacological characterization of repeated corticosterone injection-induced depression model in rats

(2010) Michihiko Iijima et al.   BRAIN RESEARCH

The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment

(2010) Rudolf Schicho et al.   INFLAMMATORY BOWEL DISEASES

601 DISTRIBUTION OF THE G-PROTEIN-COUPLED RECEPTOR 55 (GPR55) IN THE RAT BLADDER AND URODYNAMIC EFFECTS OF A SELECTIVE GPR55-AGONIST IN CONSCIOUS RATS

(2009) C. Gratzke et al.   EUROPEAN UROLOGY SUPPLEMENTS

A mouse model of depression induced by repeated corticosterone injections

(2008) Yunan Zhao et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain

(2008) Penny C. Staton et al.   PAIN

Functional and Immunohistochemical Characterization of CB1 and CB2 Receptors in Rat Bladder

(2008) Matthew H. Hayn et al.   UROLOGY

GPR55: a new member of the cannabinoid receptor clan?

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY

The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects

(2007) D G Johns et al.   BRITISH JOURNAL OF PHARMACOLOGY